Cargando…

COVID-19-related hospital cost-outcome analysis: The impact of clinical and demographic factors

INTRODUCTION: Although patients’ clinical conditions have been shown to be associated with coronavirus disease (COVID-19) severity and outcome, their impact on hospital costs are not known. This economic evaluation of COVID-19 admissions aimed to assess direct and fixed hospital costs and describe t...

Descripción completa

Detalles Bibliográficos
Autores principales: Miethke-Morais, Anna, Cassenote, Alex, Piva, Heloisa, Tokunaga, Eric, Cobello, Vilson, Rodrigues Gonçalves, Fabio Augusto, dos Santos Lobo, Renata, Trindade, Evelinda, Carneiro D`Albuquerque, Luiz Augusto, Haddad, Luciana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373618/
https://www.ncbi.nlm.nih.gov/pubmed/34454894
http://dx.doi.org/10.1016/j.bjid.2021.101609
_version_ 1783739971975249920
author Miethke-Morais, Anna
Cassenote, Alex
Piva, Heloisa
Tokunaga, Eric
Cobello, Vilson
Rodrigues Gonçalves, Fabio Augusto
dos Santos Lobo, Renata
Trindade, Evelinda
Carneiro D`Albuquerque, Luiz Augusto
Haddad, Luciana
author_facet Miethke-Morais, Anna
Cassenote, Alex
Piva, Heloisa
Tokunaga, Eric
Cobello, Vilson
Rodrigues Gonçalves, Fabio Augusto
dos Santos Lobo, Renata
Trindade, Evelinda
Carneiro D`Albuquerque, Luiz Augusto
Haddad, Luciana
author_sort Miethke-Morais, Anna
collection PubMed
description INTRODUCTION: Although patients’ clinical conditions have been shown to be associated with coronavirus disease (COVID-19) severity and outcome, their impact on hospital costs are not known. This economic evaluation of COVID-19 admissions aimed to assess direct and fixed hospital costs and describe their particularities in different clinical and demographic conditions and outcomes in the largest public hospital in Latin America, located in São Paulo, Brazil, where a whole institute was exclusively dedicated to COVID-19 patients in response to the pandemic. METHODS: This is a partial economic evaluation performed from the hospital´s perspective and is a prospective, observational cohort study to assess hospitalization costs of suspected and confirmed COVID-19 patients admitted between March 30 and June 30, 2020, to Hospital das Clínicas of the University of São Paulo Medical School (HCFMUSP) and followed until discharge, death, or external transfer. Micro- and macro-costing methodologies were used to describe and analyze the total cost associated with each patient's underlying medical conditions, itinerary and outcomes as well as the cost components of different hospital sectors. RESULTS: The average cost of the 3254 admissions (51.7% of which involved intensive care unit stays) was US$12,637.42. The overhead cost was its main component. Sex, age and underlying hypertension (US$14,746.77), diabetes (US$15,002.12), obesity (US$18,941.55), chronic renal failure (US$15,377.84), and rheumatic (US$17,764.61), hematologic (US$15,908.25) and neurologic (US$15,257.95) diseases were associated with higher costs. Age strata >69 years, reverse transcription polymerase chain reaction (RT-PCR)-confirmed COVID-19, comorbidities, use of mechanical ventilation or dialysis, surgery and outcomes remained associated with higher costs. CONCLUSION: Knowledge of COVID-19 hospital costs can aid in the development of a comprehensive approach for decision-making and planning for future risk management.
format Online
Article
Text
id pubmed-8373618
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83736182021-08-19 COVID-19-related hospital cost-outcome analysis: The impact of clinical and demographic factors Miethke-Morais, Anna Cassenote, Alex Piva, Heloisa Tokunaga, Eric Cobello, Vilson Rodrigues Gonçalves, Fabio Augusto dos Santos Lobo, Renata Trindade, Evelinda Carneiro D`Albuquerque, Luiz Augusto Haddad, Luciana Braz J Infect Dis Original Article INTRODUCTION: Although patients’ clinical conditions have been shown to be associated with coronavirus disease (COVID-19) severity and outcome, their impact on hospital costs are not known. This economic evaluation of COVID-19 admissions aimed to assess direct and fixed hospital costs and describe their particularities in different clinical and demographic conditions and outcomes in the largest public hospital in Latin America, located in São Paulo, Brazil, where a whole institute was exclusively dedicated to COVID-19 patients in response to the pandemic. METHODS: This is a partial economic evaluation performed from the hospital´s perspective and is a prospective, observational cohort study to assess hospitalization costs of suspected and confirmed COVID-19 patients admitted between March 30 and June 30, 2020, to Hospital das Clínicas of the University of São Paulo Medical School (HCFMUSP) and followed until discharge, death, or external transfer. Micro- and macro-costing methodologies were used to describe and analyze the total cost associated with each patient's underlying medical conditions, itinerary and outcomes as well as the cost components of different hospital sectors. RESULTS: The average cost of the 3254 admissions (51.7% of which involved intensive care unit stays) was US$12,637.42. The overhead cost was its main component. Sex, age and underlying hypertension (US$14,746.77), diabetes (US$15,002.12), obesity (US$18,941.55), chronic renal failure (US$15,377.84), and rheumatic (US$17,764.61), hematologic (US$15,908.25) and neurologic (US$15,257.95) diseases were associated with higher costs. Age strata >69 years, reverse transcription polymerase chain reaction (RT-PCR)-confirmed COVID-19, comorbidities, use of mechanical ventilation or dialysis, surgery and outcomes remained associated with higher costs. CONCLUSION: Knowledge of COVID-19 hospital costs can aid in the development of a comprehensive approach for decision-making and planning for future risk management. Elsevier 2021-08-19 /pmc/articles/PMC8373618/ /pubmed/34454894 http://dx.doi.org/10.1016/j.bjid.2021.101609 Text en © 2021 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Miethke-Morais, Anna
Cassenote, Alex
Piva, Heloisa
Tokunaga, Eric
Cobello, Vilson
Rodrigues Gonçalves, Fabio Augusto
dos Santos Lobo, Renata
Trindade, Evelinda
Carneiro D`Albuquerque, Luiz Augusto
Haddad, Luciana
COVID-19-related hospital cost-outcome analysis: The impact of clinical and demographic factors
title COVID-19-related hospital cost-outcome analysis: The impact of clinical and demographic factors
title_full COVID-19-related hospital cost-outcome analysis: The impact of clinical and demographic factors
title_fullStr COVID-19-related hospital cost-outcome analysis: The impact of clinical and demographic factors
title_full_unstemmed COVID-19-related hospital cost-outcome analysis: The impact of clinical and demographic factors
title_short COVID-19-related hospital cost-outcome analysis: The impact of clinical and demographic factors
title_sort covid-19-related hospital cost-outcome analysis: the impact of clinical and demographic factors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373618/
https://www.ncbi.nlm.nih.gov/pubmed/34454894
http://dx.doi.org/10.1016/j.bjid.2021.101609
work_keys_str_mv AT miethkemoraisanna covid19relatedhospitalcostoutcomeanalysistheimpactofclinicalanddemographicfactors
AT cassenotealex covid19relatedhospitalcostoutcomeanalysistheimpactofclinicalanddemographicfactors
AT pivaheloisa covid19relatedhospitalcostoutcomeanalysistheimpactofclinicalanddemographicfactors
AT tokunagaeric covid19relatedhospitalcostoutcomeanalysistheimpactofclinicalanddemographicfactors
AT cobellovilson covid19relatedhospitalcostoutcomeanalysistheimpactofclinicalanddemographicfactors
AT rodriguesgoncalvesfabioaugusto covid19relatedhospitalcostoutcomeanalysistheimpactofclinicalanddemographicfactors
AT dossantosloborenata covid19relatedhospitalcostoutcomeanalysistheimpactofclinicalanddemographicfactors
AT trindadeevelinda covid19relatedhospitalcostoutcomeanalysistheimpactofclinicalanddemographicfactors
AT carneirodalbuquerqueluizaugusto covid19relatedhospitalcostoutcomeanalysistheimpactofclinicalanddemographicfactors
AT haddadluciana covid19relatedhospitalcostoutcomeanalysistheimpactofclinicalanddemographicfactors
AT covid19relatedhospitalcostoutcomeanalysistheimpactofclinicalanddemographicfactors